We focus on two core areas: Biotech & Pharma, with real-time intelligence on clinical trials, drug development, and pipeline execution; and Regulatory Risk & Compliance, tracking federal risk signals across healthcare, infrastructure, energy, finance, and more. We continuously expand sources and partner with clients to launch new domains.

All insights come from trusted primary sources and AppliedXL’s proprietary data. We apply an Editorial AI approach with automated fact-checking, cross-source validation, and human audits, combining data structure, editorial standards, and oversight to minimize risk of AI “hallucinations.”

We don’t summarize, we surface new information. Like a journalist, our system connects signals across sources, adds domain context, and layers in proprietary event classifications. The result is unique insights that go beyond compressing documents.

Every client receives tailored content feeds aligned to their priorities set up to follow their editorial rubric. While others client may monitor similar domains, your configuration is unique, ensuring differentiated, non-commoditized insights.

You can use AppliedXL content in internal workflows, client-facing products, and owned channels (digital, print, newsletters, presentations). You may build derivative outputs with attribution. What’s not allowed is reselling or redistributing the raw feeds to third parties.

You can use our content to power and enhance your AI tools (e.g., search, discovery, recommendations). What’s not permitted is using our raw content to train standalone AI or LLMs in ways that compete with AppliedXL products, protecting both your value and our IP.